Meggle’s business group, Excipients and Technology, has appointed Alexander Torster, MBA, as its new head of sales and marketing.
Vetter, CDMO specializing in aseptic manufacturing, announced that the company’s advisory board has appointed Oliver Albrecht as a new managing director effective from April 1, 2015. Albrecht replaces Max Horn as Vetter’s managing director who left the company in June 2014.
Oliver Albrecht has more than 20 years of experience managing international, medium-sized listed companies both as a managing director and as a chief financial officer in various industries including banking, automotive, and mechanical engineering. In recent years, he was the chief financial officer for SHW AG headquartered in Aalen, Germany and also acted as an independent consultant for mid-sized companies.
Albrecht’s previous positions include senior posts at companies such as chief financial officer for centrotherm photovoltaics AG and director in the financial and banking sector. He holds a diploma in business from the University of Mannheim, Germany.
In his new role as managing director at Vetter, Albrecht will be responsible for two of the eight company divisions, the first of which is comprised of finance, controlling, and IT. The second division includes corporate development, legal, and corporate compliance.
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.